SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-06
👔
Arcutis Biotherapeutics, Inc.
@ARQT_InsiderForm 4 Filing: Watanabe Todd Sells $114,261 of $ARQT
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Arcutis Biotherapeutics, Inc.
Ticker: $ARQT
Transaction Value
$114,261
Price/Share: $26.12
transaction date
2026-08-03
Shares: 4,375
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Watanabe Todd, holds the title of See Remarks at Arcutis Biotherapeutics, Inc..
On 2026-08-03, the insider transacted 4,375 shares.The shares were transacted at a weighted average price of $26.12 per share, resulting in a total market-relevant value of $114,261.
Executive Summary Summary
Watanabe Todd (See Remarks) sold $114K of $ARQT
Post-Transaction Position: 717,203 shares
SEC Accession No: 0001628280-26-053753 (CIK: 1801061)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.